Pharmaceuticals

Boehringer Ingelheim and Lilly Revising Operational Structure of Diabetes Alliance in Certain Countries

INDIANAPOLIS and INGELHEIM, Germany, Oct. 29, 2014 /PRNewswire/ -- In a move that will strengthen their alliance by enhancing efficiencies and enabling greater focus on product launches, Boehringer Ingelheim and Eli Lilly and Company (NYSE: LLY) are changing the operational and financial structur...

2014-10-29 20:00 1254

SAFC Launches New Protein Quality Supplement to Increase N-linked Glycosylation

ST. LOUIS, Oct. 29, 2014 /PRNewswire/ -- Sigma-Aldrich® Corp. (NASDAQ: SIAL) today announced that SAFC® Commercial (www.safcglobal.com ), its custom manufacturing services business unit, has introduced a new protein quality supplement called EX-CELL® Glycosylation Adj...

2014-10-29 19:00 1786

New, Convenient Option Aims to Improve Asthma Management for Sufferers in Singapore

SINGAPORE, Oct. 24, 2014 /PRNewswire/ -- Mundipharma announced today the launch inSingapore of flutiform®, a new combination therapy for the maintenance treatment of asthma.flutiform® combines for the first time two of the most effective asthma medications[1] in a single, portable aerosol inhaler...

2014-10-24 17:48 2548

PneumRx Completes RENEW Pivotal Trial Enrollment

MOUNTAIN VIEW, Calif., Oct. 20, 2014 /PRNewswire/ -- PneumRx, Inc. ( www.pneumrx.com ), a leader in the field of interventional pulmonology, today announced completion of enrollment in their RENEW Study, nearly 3 months ahead of schedule.  The RENEW Clinical Study is the ...

2014-10-20 08:36 2161

DKSH Extends Relationship with Roche Across Asia

BANGKOK and HONG KONG, Oct. 17, 2014 /PRNewswire/ -- DKSH Business Unit Healthcare, a leading partner for healthcare companies seeking to grow their business inAsia, will continue to provide Market Expansion Services for Roche's full pharmaceutical product portfolio inCambodia, Hong Kong, Laos,...

2014-10-17 17:41 2433

Infinitus' New Base in China Established for Production

YINGKOU, China, Oct. 17, 2014 /PRNewswire/ -- On 16 October, Infinitus Yingkou Production Base (hereinafter referred to as "the Base"), the second production base of LKK Health Products Group (LKKHPG) in the Chinese mainland was put into production, which symbolized that the strategic layout of "...

2014-10-17 09:30 2553

Infinitus' New Base in China Established for Production

YINGKOU, China, Oct. 17, 2014 /PRNewswire/ -- On 16 October, Infinitus Yingkou Production Base ("the Base"), the second production base of LKK Health Products Group (LKKHPG) in the Chinese mainland, was put into production, which symbolized that the strategic layout of "one South Base and one Nor...

2014-10-17 09:30 2731

Complementary Medicine Use Linked to Healthcare Cost Savings, Finds Frost & Sullivan

SYDNEY, Oct. 15, 2014 /PRNewswire/ -- Escalating healthcare costs associated with the increasing burden of disease inAustralia is a major challenge for government, private health insurers and individuals. Thus, there is growing pressure to find solutions to improve health outcomes and reduce heal...

2014-10-15 07:26 1638

Initial Pharmacokinetic Data From TRIBECA Study Support Potential For Bioequivalence Between Cynviloq And Albumin-Bound Paclitaxel

SAN DIEGO, Oct. 15, 2014 /PRNewswire/ -- Sorrento Therapeutics, Inc. (NASDAQ: SRNE; Sorrento), an oncology company developing new treatments for cancer and associated pain, announced today positive results from recently analyzed pharmacokinetic (PK) data from the first eight (8) patients enrolled...

2014-10-15 04:44 2270

Abbott Celebrates the Power of Health and Achievement as First-Ever Title Sponsor of World Marathon Majors

ABBOTT PARK, Illinois, Oct. 10, 2014 /PRNewswire/ -- Abbott (NYSE: ABT) and the World Marathon Majors announced a new partnership with Abbott becoming the race series' first-ever title sponsor. The series – comprising six of the largest and most renowned marathons in the world:Tokyo, Boston, Virg...

2014-10-10 23:06 2762

Manuela Leone MD Joins Aptuit Leadership Team As Executive V.P. And Verona General Manager

GREENWICH, Connecticut, Oct. 10, 2014  /PRNewswire/ -- Aptuit LLC announced the appointment of Dr.Manuela Leone as Executive Vice President, Operations and General Manager of the Aptuit Center for Drug Discovery & Development in Verona, Italy. In this role, Dr. Leone will be overseeing Aptuit's dr...

2014-10-10 01:30 2334

In Vitro Diagnostics Players Go Global, says Frost & Sullivan, as US and Europe Markets Slow Down

MOUNTAIN VIEW, California, Oct. 10, 2014 /PRNewswire/ -- Despite economic and industry challenges, the global in vitro diagnostics (IVD) market is growing robustly – at double the rate of the global pharmaceutical industry. The market will remain buoyant as the recent success of cost-saving compa...

2014-10-10 00:25 2393

BioXcel to Present 'The World Data Impact on Pharma R&D Strategy' at Phacilitate Big Data Leaders' Forum 2014 in Washington D.C.

BRANFORD, Conn., Oct. 8, 2014 /PRNewswire/ -- BioXcel Corporation, a pioneer in Pharma Big Data analytics solutions, today announced that Dr.Vimal Mehta, CEO and Chairman of BioXcel, will present at the 2014 Phacilitate Big Data Leaders' Forum with AstraZeneca. The presentation will take place on...

2014-10-08 17:00 1513

1st and largest multi-country study in Asia reveals patients require better specialist care and pharmacotherapy to treat the growing burden of pain

SINGAPORE, Oct. 6, 2014 /PRNewswire/ -- Results from the first and largest cross-sectional evaluation of physicians' and patients' perspectives on cancer and non-cancer pain management in 10 Asian countries have revealed the pressing need to improve pain diagnosis and management for patients inAs...

2014-10-06 10:55 1871

Norgine Enrols First Patient in the Phase III NOCT Study to Evaluate Bowel Cleansing Efficacy of NER1006, a Novel, Low Volume Bowel Preparation, vs. Trisulfate

LONDON, October 3, 2014 /PRNewswire/ -- Norgine today announced the enrolment of the first patient into the US Phase III study, NOCT, for its investigational product NER1006. This study will evaluate the bowel cleansing efficacy of a two-day split-dosing regimen of NER1006, versus a split-dosin...

2014-10-03 14:00 2517

Frost & Sullivan Confers Technology Innovation Leadership Award on ADOCIA for its Robust Pipeline of Novel Therapeutic Proteins

LONDON, Sept. 29, 2014 /PRNewswire/ -- Based on its recent analysis of the therapeutic proteins market, Frost & Sullivan recognises ADOCIA with the 2014 European Frost & Sullivan Award for Technology Innovation Leadership. By adopting a flexible business model that promotes partnerships and co...

2014-09-29 23:59 1112

Boehringer Ingelheim's afatinib Achieves Primary Endpoint in Global Phase III Study in Recurrent/Metastatic Head and Neck Squamous Cell Cancer

INGELHEIM, Germany, Sept. 27, 2014 /PRNewswire/ -- * Results from the LUX-Head & Neck 1 study show afatinib* significantly delayed tumour growth versus chemotherapy in patients following failure of their previous treatment, reducing the risk for disease progression by 20% * Head and neck can...

2014-09-27 15:00 1827

Daiichi Sankyo Receives Approval for Additional Indications of LIXIANA® (edoxaban) in Japan

TOKYO, Sept. 26, 2014 /PRNewswire/ -- Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) today announced that it received approval from the Ministry of Health, Labour and Welfare inJapan for LIXIANA® (JAN: Edoxaban Tosilate Hydrate, INN: edoxaban) for the prevention of ischemic stroke an...

2014-09-26 19:57 1880

World Heart Federation Announces a Donation from Bristol-Myers Squibb and Pfizer for a Program to Help Improve Experiences for People with Atrial Fibrillation (AF)

GENEVA, Sept. 25, 2014 /PRNewswire/ -- AF is the most common type of heart arrhythmia in the world, responsible for 15 - 20 per cent of strokes which affect the brain   The World Heart Federation (WHF) is delighted to announce a charitable donation from the pharmaceutical companies Bristol-Myer...

2014-09-25 02:46 2387

Equashield Enters Taiwan Following Expansion to Australia, Japan, China

PORT WASHINGTON, N.Y., Sept. 23, 2014 /PRNewswire/ -- Equashield ( http://www.equashield.com/ ), a leading provider of  Closed System Transfer Devices (CSTD) for hazardous drugs, announced today a new exclusive partnership with Taiwanese distributor MedFront Medical T...

2014-09-23 08:00 1819